|
(BS246) |
Treating cardiac fibrosis with natural compound-derived small molecules |
| |
|
F. Kreutzer, A. Meinecke, S. Mitzka, F. Perbellini, C. Terracciano, J. Fiedler, T. Thum (Hannover; London, UK) |
|
(BS247) |
Inhibition of ADAM10 in combination with LCZ696 improves survival and augments cardiac function after myocardial infarction |
| |
|
E. Klapproth, S. Weber, M. Günscht, S. Künzel, K. Lorenz, K. Guan, A. El-Armouche (Dresden, Würzburg) |
|
(BS248) |
A PKA/proteasome and Hsp90-Dependent Signaling Pathway Regulates Mitochondrial Complex I Function during Cardiomyocyte Maturation |
| |
|
A. Ebert, für die Studiengruppe: DZHK (Göttingen) |
|
(BS249) |
The mechanical effect of protein kinase G-dependent Ca2(+)/calmodulin-dependent protein kinase-II phosphorylation and CaMKII oxidation on cardiomyocyte function |
| |
|
M. Herwig, S. Pabel, S. Zhazykbayeva, Á. Kovács, S. Ghaderi, D. Kolijn, D. Cimiotti, E. Robinson, V. Nikolaev, K. Jaquet, S. Heymans, S. van Linthout, A. Mügge, C. Tschöpe, S. T. Sossalla, N. Hamdani (Bochum, Regensburg, Hamburg, Berlin; Maastricht, NL) |
|
(BS250) |
The specific cleavage of titin springs to determine the contribution of titin to myocardial passive stiffness |
| |
|
J. Freundt, J. Recker, I. Liashkovich, C. Loescher, J. Fernandez, W. A. Linke (Münster; New York, US) |
|
(BS251) |
CaMKII decreases PKA activity by phosphorylation of its regulatory subunit R1α |
| |
|
M. van den Hoogenhof, S. Spaich, S. Gremer, C. Dieterich, M. Kruger, J. Backs (Heidelberg, Köln) |
|
(BS252) |
Adenine nucleotide translocase 1 overexpression increases cell-protective HSP27-mediated TLR4-signaling |
| |
|
J. Winter, J. Heger, H.-P. Schultheiss, U. Landmesser, A. Dörner (Berlin, Gießen) |
|
(BS253) |
A novel mouse model of obstructive sleep apnea develops contractile dysfunction and CaMKII overexpression |
| |
|
S. Lebek, C. Schach, K. Reuthner, M. Tafelmeier, D. Camboni, L. Rupprecht, C. Schmid, L. S. Maier, M. Arzt, S. Wagner (Regensburg) |